Skip to content

Kite Pharma, Inc.

CIK 0001510580

← back to feed
Revenue (TTM)
$32.02M
−33.2% YoY Q2 Aug 2017
Net Income (TTM)
−$338.44M
−162.7% YoY Q2 Aug 2017
EPS Diluted (TTM)
—
Q2 Aug 2017
Gross Margin
—
Q2 Aug 2017
Operating Margin
-1,046.3%
Q2 Aug 2017
Net Margin
-1,056.8%
Q2 Aug 2017
Free Cash Flow (TTM)
−$183.48M
Q2 Aug 2017
Cash
$147.84M
Q2 Aug 2017
Total Debt
—
Q2 Aug 2017
Shares Outstanding
57.18M sh
Q2 Aug 2017

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings